Atlas Trials

UBATEC

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch UBATEC

RecordFirmDate
Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH) (NCT06967753)UBATEC2025-07-31

Track UBATEC automatically

Every clearance here is in the API, with alerts when new ones post.